Newlife to develop wristwatch heart rate monitor:
This article was originally published in Clinica
Executive Summary
US company Newlife Technologies is to use technology licensed from BTG International to develop a wristwatch-like device that can noninvasively monitor vital signs in the human body, such as heart rate. The technology consists of an optical fibre sensor that can pick up physiological changes in the body through the strap, Steve Burton, Newlife's president told Clinica. The Midlothian, Virginia-based company will use the technology to enhance its FDA-approved heart rate monitoring product, the HEARTalker, which vocally feeds back ECG measurements from a strap worn around the chest to assist the user during personal training.
You may also be interested in...
Majority Of Spanish OTC Firms Investing Heavily In Digital
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Novartis Targets Ten Indications For Cosentyx
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: